Nasopharyngeal Carcinoma

1. A Phase I Trial of 5Azacitidine and Suberoylanilide hydroxamic acid in Patients with Metastatic or Locally Recurrent Nasopharyngeal Carcinoma and Nasal NK-T cell Lymphoma (NCI study).
2. A Phase 2 Study of GW786034 (Pazopanib) in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma (NCI study).

Hepatocellular Carcinoma

1. A Phase 2 Study of GW786034 (Pazopanib) in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma

Pharmacogenetics

1. The effect of pharmacogenetics on treatment toxicities and outcomes in East Asian and Caucasian patients undergoing docetaxel or gemcitabine-based chemotherapy.

Multiple Myeloma

1. MC0888 - Phase II Trial of Cdk Inhibitor SCH 727965 in Multiple Myeloma

Thyroid Cancer

1. A Phase II Trial of GW786034 in Advanced Thyroid Cancer (NCI study in collaboration with Mayo Phase II Consortium).